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Nicotinic acetylcholine receptors (AChRs), implicated in memory and learning, in subjects aﬀected by Alzheimer’s disease result
altered. Stimulation of α7-nAChRs inhibits amyloid plaques and increases ACh release. β-amyloid peptide (AβP) forms ion
channels in the cell and model phospholipid membranes that are retained responsible in Alzheimer disease. We tested if choline,
precursor of ACh, could aﬀect the AβP1-40 channels in oxidized cholesterol (OxCh) and in palmitoyl-oleoyl-phosphatidylcholine
(POPC):Ch lipid bilayers. Choline concentrations of 5 × 10−11 M–1.5 × 10−8 M added to the cis-o rtrans-side of membrane
quickly increased AβP1-40 ion channel frequency (events/min) and ion conductance in OxCh membranes, but not in POPC:Ch
membranes.CircularDichroism(CD)spectroscopyshowsthatafter24and48hoursofincubationwithAβP1-40,cholinestabilizes
the random coil conformation of the peptide, making it less prone to ﬁbrillate. These actions seem to be speciﬁc in that ACh is
ineﬀective either in solution or on AβP1-40 channel incorporated into PLMs.
1.Introduction
Alzheimer’sdisease(AD)isanage-relatedneurodegenerative
disorderthatischaracterizedbyaprogressivelossofmemory
and deterioration of higher cognitive functions. The wealth
of evidence of early and major synaptic damage and loss [1,
2], correlated with the severity of dementia [3–5], considers
AD to be a disorder of synaptic function [6, 7].
Cholinergic neurons show particular vulnerability in the
ageing process, which causes chronic deterioration of the
braincomponent.Itisawidespreadbeliefamongresearchers
that AβP peptides are involved in the loss of cholinergic
neurons from the basal forebrain area in AD. Moreover, the
mechanisms by which AβP peptides inﬂuence/cause degen-
eration of basal forebrain cholinergic neurons and/or the
cognitive impairment characteristic of AD remain obscure,
although there is little doubt that early synaptic pathology
precedes the clinical symptoms of AD [8, 9].
Several hypotheses have been formulated to explain the
onset of this disease such as: alterations in choline uptake,
choline transport, impaired acetylcholine release, deﬁcits
in expression of nicotinic, and muscarinic receptors and
channel formation by AβP oligomers. An increase in choline
ﬂux across the membranes of neuronal cells exposed to AβP
has also been hypothesized to contribute to the selective
vulnerability of cholinergic neurons in AD [10].
AβP is an amphiphilic peptide with a hydrophilic N-
terminal domain (residues 1–28) and a hydrophobic C-
terminal (residues 29–40 (−42)), the latter corresponding
to a part of the transmembrane domain of APP. CD
studies have shown that AβP changes its conformation
from lipid-free AβP in order to bind to phospholipid
vesicles. AβP consists of 48.9% random-coil, 23.5% β-sheet,
and 1.7% alpha-helix; while when reconstituted in phos-
pholipid vesicles made up of 1,2-dimyristoyl-sn-glycero-3-
phosphocholine, both β-sheet and α-helix contents increase
by about 7%, that is, the β-sheet increased to 31.2%
and the α-helix to 9.5%, respectively [11]. It has been
demonstrated that AβP forms ion channels in the cell
and model phospholipid membranes [12–14]; a PK
+/PCl
−
permeability ratio of 11, with calcium permeability blocked
by tromethamine and aluminium, has been reported [12].
Moreover, AβPdisruptedcalciumhomeostasisandincreased
calcium intracellular concentrations; these events may be2 International Journal of Alzheimer’s Disease
responsible for cellular toxicity [15]. Recent studies indicate
that the peptide’s ability to form ion channels depends on its
conformational structure and on the peptide/lipid structure
in the physiological environment. Some authors have found
that membrane components, such as cholesterol (Ch) and
gangliosides, alter the aﬃnity of AβP for phospholipid
membranes. In fact, Ch and gangliosides, once associated
with phospholipid membranes, lead to an increase in β-
sheet content and/or the rate of aggregation of AβP[ 16].
On the other hand, other authors have shown that, when
AβP was added to a 33% Ch-containing 1,2-dimyristoyl-sn-
glycero-3-phosphocholine vesicle, the structure of AβPw a s
drastically altered, that is, the β-sheet structure decreased to
zero while the α-helix increased to 58.8% [11]. In addition,
alterations to the soluble Ch concentration and/or in Ch
biosynthesishavebeenshowntoaﬀectthenormalprocessing
of APP, both in vivo and in vitro [17]. In a previous study,
we investigated the role played by membrane composition
on the interaction and self-assembly of AβP1-40 during pore
formation in PLMs. This study showed that AβP1-40 has
a higher propensity to form channels in OxCh PLM (as
comparedtootherneutralphospholipidPLMs,whetherthey
contain sterols or not), where the channels present high con-
ductance, high frequency, anion selectivity, and long lifetime
[14].
In this study, we investigated the eﬀects of choline on
the AβP1-40 ion channel in lipid bilayer membranes made
up of OxCh and of POPC:Ch bilayer. OxCh membranes
were used due to the evidence of a Ch-rich domain both
in eukaryotic plasma membranes—such as brain and blood
vessels—and in aged membrane plaque. Besides, AβP1-40
shows a higher aﬃnity to Ch and its oxidation products than
to phospholipids [14].
2.MaterialsandMethods
2.1. Single Channel Measurement. Channel activities were
recorded in a lipid bilayer membrane made up of OxCh in
n-decane (1:1, v:v) (Fluka) or POPC:Ch (65:35, w/w) in
1% n-decane. OxCh was obtained following the method of
Tien et al. [18]. Bilayers were formed across a 300μmh o l ei n
a Teﬂon partition separating two Teﬂon chambers (volume
4000μl) which held symmetrical 50mM KCl solutions,
pH = 7, temperature 23 ± 1◦C. The aqueous solutions were
used unbuﬀered. The salts used in the experiments were of
analytical grade. In all peptide experiments performed, the
conductance and capacitance of each membrane was tested
by applying a voltage of ±100mV for 10–15 minutes under
stirring to ensure that the membrane was stable.
A stock solution of AβP1-40 (Sigma or EZBiolab) was
prepared by dissolving AβP1-40 powder (0.1mg) in 100μl
of bidistilled sterile water under stirring for 3 minutes.
From this solution, 5μl were withdrawn and diluted in
45μl of bidistilled sterile water under stirring for 3 minutes.
Both solutions were stored at −20◦C until use and 8.7μl
of the second solution was added to the cis-side of the
membrane, to obtain the ﬁnal concentration of 5×10−8 M.
After AβP1-40 ion channel formation, few μl of scalar
dilution of choline (Fluka) stock solutions (1×10−3;1 ×10−5;
1×10−7;1 ×10−8 M) were added to obtain the ﬁnal desired
concentration on the cisor transside of the Teﬂon chambers.
The solutions were stirred after each addition of AβP1-40 or
choline for 1 minute.
In single-channel experiments, the membrane current
was monitored with an oscilloscope and recorded on a
chart recorder for further data analysis by hand. The cis
and trans chambers were connected to the ampliﬁer head
stage by Ag/AgCl electrodes in series with a voltage source
and a highly sensitive current ampliﬁer. The single-channel
instrumentation had a time resolution of 1–10msec depend-
ing on the magnitude of the single-channel conductance.
The polarity of the voltage was deﬁned according to the
side where AβP was added (the cis-side). A trans-negative
potential (indicated by a minus sign) means that a negative
potential was applied to the trans side, the compartment
opposite the one where AβPw a sa d d e d .
The phenomenology of AβP1-40 incorporation and
choline action was studied as follows:
(i) to deﬁne the voltage-dependent characteristics of
AβP1-40, we measured the amplitude of channel
events at each membrane potential applied,
(ii) to deﬁne the channel lifetime, from records extend-
ing over prolonged periods, the channel duration
was measured considering the time between the
opening and closing of each channel. The single
channel data were obtained from at least two and
sometimes four experiments (more than 100 single
channels for each experiment) performed on dif-
ferent days. A histogram of channel conductance
distributionforeachexperimentwasconstructedand
ﬁtted by a Gaussian distribution function (Graph-
Pad Prism version 3.0; GraphPad Software Inc.,
http://www.graphpad.com/). Results are expressed as
mean ± SE. The average lifetime of the conductance
unit was estimated by the formula
N = A1e(−t/τ1) +A2e(−t/τ2) (1)
where N is the number of channels that remain
open for a time equal to or greater than a certain
time t, A1 and A2 are the zero time amplitudes,
and τ1 and τ2 are related to the fast and slow
components of the time constant, respectively. The
single-exponential distribution is included in the
formula (A2 = 0). To choose between the two
models, we performed an appropriate statistical test
(F-test, Graph Pad Prism version 3.0; Graph Pad
Software, Inc, http://www.graphpad.com/)
(iii) to identify the charge on the ion carrying the current,
we measured the shift in the reversal potential
induced by a change from a symmetrical to an asym-
metrical KCl solution system. When the membrane
conductance reached a virtually stable value, after
addition of AβP1-40 to the cis chamber,we added
choline to the cis or trans side. After stabilizing
the membrane conductance, the KCl concentration
was raised to 100mM by adding concentrated salt
solution to the cis side of the chamber.International Journal of Alzheimer’s Disease 3
The reversal potential was determined by changing the
holding potential of ±4mV step by step, and the potential at
whichthecurrentwaszerowastakenasthereversalpotential
for the open channel.
The permeability ratio was calculated using the
Goldman-Hodgkin-Katz equation
V =

RT
F

∗ln

(PK[K]t +PCl[Cl]c)
(PK[K]c +PCl[Cl]t)

,( 2 )
where [X]t and [X]c are the concentrations of the ion
species X in the transand ciscompartments, respectively and
where R, T and F are molar gas constant, thermodynamic
temperature and Faraday constant, respectively.
2.2. Circular Dichroism Measurement. CD spectra were
recorded on a Jasco J-810 spectropolarimeter at 23 ± 1◦C.
Cells with a path length of 1cm were used for spectra
recorded between 200 and 260nm, with sampling points
every 0.5nm. The AβP1-40 stock solution concentration
was 5.77 × 10−5 M. The aqueous buﬀer used to dissolve
the peptide was 50mM KCl pH 7. Peptide samples were
prepared from stock solution at a concentration of 5.77 ×
10−6 Min50mMKClpH7.Samplescontainingcholinewere
prepared by adding choline chloride at a concentration of
5.77 × 10−9 Mo r5 . 7 7× 10−8 M to the AβP1-40 samples, the
same ratio (1:1000 or 1:100, resp.) of choline: AβP1-40 that
was used in channel experiments. CD spectra were recorded
5 minutes, 24, and 48 hours after preparing the samples.
Each CD spectrum consisted of ﬁve consecutive scans at a
scanning speed of 20nm/min. The samples were stored at 23
± 1◦C for subsequent analysis.
2.3. Choline Permeability across OxCh Membrane without and
with AβP1-40 Channel Activity. Choline permeability was
measured as follows: when the membrane turned “black”
in the control experiments or when AβP1-40 manifested
its channel activity and in the open state of the channel,
4μl of ethanol containing 4μCi of the labelled choline
([3H]choline, Perkin-Elmer) were added to the cis side; the
same amount of unlabeled choline solution was added to the
opposite side. The solution was stirred mechanically. After
30 minutes, 10μlo fﬂ u i df r o mb o t hs i d e sw a sc o l l e c t e d .
The radioactivity readings were performed with an LS 6500
MultipurposeScintillationCounter(BeckmanCoulter,USA)
andthepermeabilitycoeﬃcientcalculated.Meanvalues ±SE
of 3 experiments for each set of experiments are reported.
3. Results
3.1. Eﬀect of Choline on AβP1-40 Channel Conductance. In
this study, we evaluated the eﬀect of choline on the AβP1-40
ion channel incorporated into PLMs made up of OxCh or
POPC:Ch.
First of all, in order to exclude any nonspeciﬁc and
destabilizing eﬀect of choline per se on PLMs used, we
performed experiments by leaving choline in the medium
facing the membrane for up to 24 hours. The stability of the
PLM was tested by applying a voltage of ±100mV for 10–
15 minutes under stirring and monitoring constant values
for conductance (25pS) and capacitance (0.32μF/cm2);
choline, over the range of concentrations used in the present
work, caused no variations in membrane conductance and
capacitance in bare membranes.
The incorporation of AβP1-40 (added to the cis side of
the medium facing the membrane) into the lipid bilayer
leads to nonrandom discrete square events that ﬂuctuate
between conductive and nonconductive states, compatible
with channel-type openings, and closures with diﬀerent
conductance levels, lifetime and frequency. The pattern is
similar to that found in our previous study [14], that is, we
found higher conductance for the AβP1-40 channel incor-
porated into OxCh PLM. Figure 1 shows examples of chart
recordings of AβP1-40 channel formation in OxCh PLMs.
When the AβP1-40 channels ﬂuctuated in the open
state in OxCh PLMs, choline (5×10−11 M) was added to
the cis or trans side of the medium facing the membrane.
In a short time (about 5/30 minutes, cis/trans,r e s p . )
choline determined an increase in AβP1-40 ion channel
activity characterized by more frequent multiple levels of
conductance.Furthermore,thesepatternsweremoreevident
at positive applied voltages. Figure 2 reports the histograms
of conductance distribution for each experimental condition
used in OxCh PLMs. All the histograms show single-peaked
conductance distributions. The central value of conductance
(Λc) obtained by the Gaussian best-ﬁt characterizes
the conductance state of AβP1-40 channels in various
membranes. Figure 3(a) reports the central value of Λc ± SE
at the diﬀerent applied voltages for diﬀerent experimental
conditions in OxCh PLMs. In the presence of choline, no
matter which side it is added, the Λc values are signiﬁcantly
higher at positive applied voltages than at negative ones
(P<. 0001 and P ≤ .0012 for choline added on the cis and
on the trans side, resp.). If we compare the eﬀect of choline
on AβP1-40 channel conductance, it can be seen that choline
a d d e do nt h etrans side increases channel conductance more
than when added to the cis side.
Figure 4 shows typical examples of single-channel chart
recordings of AβP1-40 channel formation with associated
conductancedistributionhistogramsinOxChPLMswithout
and with successive additions of choline to the cis-side of the
medium facing the membrane or when choline in a ratio
of about 1:3 to the peptide (1.5×10−8 M) was added when
the channel was ﬂuctuating in the open state. It can be seen
that single-channel activity sometimes occurred in highly
variable steps, yet the frequency of channels increases by
increasing the choline concentration; we also observed alter-
nating periods of paroxystic channel activity, during which
it is impossible to make a rigorous analysis of the number
of channels, followed by quiescent periods that are more
frequents at higher choline concentration and often followed
by membrane destabilization until rupture. Furthermore, a
t-test showed that the central channel conductance of AβP1-
40 is statistically increased when choline at diﬀerent concen-
trations is added to the cis-side (see capture of Figure 4).
Yet, the same result was found when choline at diﬀerent
concentrations was added to the trans side (data not shown).4 International Journal of Alzheimer’s Disease
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Figure 1: AβP1-40 channel activity in OxCh PLM in the absence and in the presence of choline. Representative AβP1-40 channel in the
absence (a), in the presence of choline on the cis (b), or on the trans (c) side of the medium facing an OxCh PLM at an applied voltage of
±60mV. Each trace represents a fragment of the recording of the activity obtained in individual experiments. Note the increased activity of
the channel and the frequent multiple levels of conductance, especially at positive applied voltages, when choline is present. Experimental
conditions KCl 50mM, AβP1-40 5 ×10−8 M were present to the cis side of the membrane, choline 5 ×10−11 Mw a sa d d e do nt h ec i so rt r a n s
side of the membrane.
Figure 5 shows examples of chart recordings of AβP1-40
channel formation in POPC:Ch PLMs. In these PLMs, no
matter if choline is added to the cis or the trans side of the
membrane,itdoes notincrease AβP1-40ionchannel activity
or conductance, nor does it modify the voltage dependence
and the Λc values of the AβP1-40 channel (Figure 6(a)). The
Λc values of the AβP1-40 channel in POPC:Ch PLMs are
lower than those in OxCh PLMs.
Our results indicate that the presence of choline (on the
cis or trans side) does not modify the voltage dependence of
AβP1-40 channels in OxCh or POPC:OxCh PLMs (Figures
3(a) and 6(a)).
3.2. Eﬀect of Choline on AβP1-40 Channel Frequency and
Lifetime. The AβP1-40 frequency values are generally higher
at positive than those at negative applied voltages in OxCh
PLMs (Figure 3(b)). Adding choline (5 × 10−11 M) to the
cis or trans side doubled and trebled, respectively, the mean
frequency values of the AβP1-40 channel at positive applied
voltages. On the other hand, at negative applied voltages,
cholineexertsnoeﬀectonAβP1-40channelfrequency,either
when present on the cis or on the trans side of the medium
facing the membrane. The frequency increases as a function
of choline concentration, and this increase occurs early. In
fact, the frequency of AβP1-40 channel was: 7.73 ± 0.34
without choline, 15.97 ± 0.53 for a choline concentration
of 5 × 10−11 M, 10.56 ± 0.40 for a choline concentration of
1×10−10 M, and 11.85 ± 0.60 for a choline concentration of
1.5 × 10−18 M. It is worth noting that these last two values
are underestimated owing to the paroxystic activity (seeInternational Journal of Alzheimer’s Disease 5
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Figure 2: Amplitude histograms of AβP1-40 channel conductance. The histograms of the probability, PΛ, for the frequency of a given
conductivity unit, relatives to each trace reported in Figure 1, were ﬁtted by a Gaussian which is shown as a solid curve.6 International Journal of Alzheimer’s Disease
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Figure 3: AβP1-40 channel mean conductance and frequency in
OxCh PLM in the absence and in the presence of choline. (a) Λc ±
SE and (b) frequency ± SD of AβP1-40 channel without and with
choline (5 × 10−11 M) added to the cis or trans side of the chamber
in OxCh PLM. The minimum and maximum number of channels
considered (N) out of a total number of channels considered (Nt)
was: AβP1-40, 448 <N<2080, Nt = 5493; AβP1-40 + choline
cis, 115 <N<898, Nt = 2269; AβP1-40 + choline trans, 448 <
N<948, Nt = 3844.
Figure 4). In POPC:Ch PLMs, AβP1-40 channel frequency
is not sensitive to the presence of choline on the cis or trans
side of the membrane (Figure 6(b)).
Another parameter used to characterize a channel is its
lifetime. Single-channel current recordings with a conspicu-
ous number of channels were analysed to obtain cumulative
open-state lifetime distributions that are reported for the
diﬀerent experimental conditions. In OxCh PLMs, analysis
of the open-time distributions for AβP1-40 single channels
is reported in Table 1, where the functions with statistically
signiﬁcant better description are indicated. It can be noted
that at positive applied voltages the fast channel lifetime
component prevails (P<. 05), whereas at negative applied
voltages the channel manifests both the fast and slow
components of lifetime (P<. 05), except for at −20mV
where it does not clearly distinguish between single and
double exponentials (P = .102).
When choline is on the cis or trans side, the results of the
open time distribution analysis for all positive and for low
negative applied voltages indicate a statistically signiﬁcant
better description (P<. 05) for two-exponential functions;
except for −40 and −60mV (choline cis)a n d−60mV
(choline trans) where there is a statistically signiﬁcant
better description (P<. 05) for one-exponential functions,
however the values of τ1 in the presence of choline are
higher than that of AβP 1 - 4 0 .T h ep r e v a l e n c eo fd u a lc h a n n e l
populations or the higher values of τ1 clearly indicates that
choline (either cis or trans) seems to stabilize the AβP1-40
single channel.
In POPC:Ch PLMs, analysis of the open-time distribu-
tion for AβP1-40 single channels does not clearly distinguish
between single and double exponentials (at applied voltages
in this study) (P ≥ .078). When choline is on the cis
side, the results of open-time distribution analysis indicate
a statistically signiﬁcant better description (P<. 05) for one-
exponential functions, except at applied voltages of 100mV
where it does not clearly distinguish between single and
double exponentials (P = .39). When choline is on the
trans side, the results of open time distribution analysis
give a statistically signiﬁcant better description (P<. 05)
for a one-exponential function at an applied voltage of 60
mV, whereas it does not clearly distinguish between single
and double exponentials at an applied voltage of 80mV
(P = .37). At an applied voltage of 100mV, the number
of channels is not conspicuous enough to provide a reliable
analysis of open-time distribution (Table 2). In any case, the
addition of choline, either on the cis or the trans side, does
not seem to modify the lifetime and stability of the ion
channel.
3.3. Ion Selectivity. The ion selectivity of AβP channels in
OxCh or POPC:Ch membranes in the presence of choline in
the cis or trans medium was determined by means of reversal
potential and I-V relationship at diﬀerent transmembrane
potentials under asymmetrical solution conditions (see
methods).
In OxCh PLMs, the PK
+/PCl
− calculated by (2)w a s
0.50/0.38 cis/trans, respectively.
ApproximatelythesameresultwasobtainedwiththeI-V
curve (Figure 7), where the amplitude of the channel events
at each membrane potential was used. In fact, the reversal
potential was 6.42mV with choline in the cis chamber and
6.87mVwithcholineinthetranschamber;theselectiveratio
PK
+/PCl
− was 0.46/0.43 cis/trans, respectively. These results
seem to indicate that the ion selectivity toward anions of the
AβP1-40 channel in OxCh PLMs [14] is not modiﬁed by the
presence of choline.
The ion selectivity of the AβP1-40 channel in POPC:Ch
PLMs remains anionic; in fact, the reversal potential was
9.76mV and the PK
+/PCl
−was 0.28.
When choline was present on the cis/trans side the
reversal potential was 5.76/7.76mV and the PK
+/PCl
− was
0.50/0.38 respectively. Approximately the same result was
obtained with the I-V curve (Figure 8). In fact, the reversal
potential was 8.99mV in the absence of choline, with a
selective ratio PK
+/PCl
− of 0.32. The reversal potential was
6.67mV with choline in the cis chamber and 6.47 mV with
choline in the trans chamber; with a selective ratio PK
+/PCl
−
of 0.44/0.45 cis/trans,r e s p e c t i v e l y .International Journal of Alzheimer’s Disease 7
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Figure 4: AβP1-40 channel activity in OxCh PLM in the absence and in the presence of diﬀerent choline concentrations. Experiments were
performed on an OxCh PLM in the presence of diﬀerent concentrations of choline added or in the presence of high choline concentrations
on the cis-side of the medium; the applied voltage was set at 60mV; the arrows indicate the choline additions when the AβP1-40 channel
ﬂuctuates in the open state. The channel central conductance (nS ± SE)/frequency (events/min ± SD) without and with choline added
to the medium was: AβP1-40 = 0.161 ± 0.008/7.73 ± 0.34; AβP1-40 + choline (5×10−11 M) = 0.215 ± 0.007/15.97 ± 0.53; AβP1-40 +
choline (1×10−10 M) = 0.179 ± 0.004/10.56 ± 0.40; AβP1-40 + choline (1.5×10−8 M) = 0.168 ± 0.001/11.85 ± 0.60. The number of channel
considered was: AβP1-40 = 505; AβP1-40 + choline (5×10−11 M) = 898; AβP1-40 + choline (1×10−10 M) = 652; AβP1-40 + choline (1.5
×10−8 M) = 358. Amplitude histograms of channel conductance for each trace are shown below traces.
Table 1: The channel lifetime of AβP1-40 in OxCh PLM. The ﬁtted lifetime (see text) of AβP1-40 in the absence (a) and in the presence of
choline (5 ×10−11 M) added on the cis/trans side of the medium facing the OxCh PLM (b/c, resp.). The minimum and maximum number
of channels considered (N) out of a total number of channels considered (Nt) was: (a) 125 <N < 503, Nt = 1214; (b) 95 <N<217,
Nt = 834; (c) 102 <N<186, Nt = 857. F-test, ∗P = .102.
Vs (mV) abc
τ1 (s) τ2 (s) τ1 (s) τ2 (s) τ1 (s) τ2 (s)
60 2.07 1.53 8.34 1.45 7.76
40 3.56 1.88 19.61 1.58 8.46
20 1.12 1.29 20.01 1.17 6.49
−20 1.05
∗ 2.23 32.26 0.25 5.03
−40 1.17 4.96 3.69 0.15 3.94
−60 1.33 8.99 2.23 2.54
3.4. Eﬀect of Choline on AβP1-40 Secondary Structure. To
test whether choline modiﬁes the secondary structure of
AβP1-40, we carried out CD experiments using AβP1-40
samples in the absence or in the presence of choline in
a molar ratio of 1:100 and 1:1000 choline:AβP. Figure 9
shows the CD spectra of AβP1-40 without and with choline
measuredafter5minutes(T0),24hours(T24),and48hours
(T48).
The CD spectra qualitatively indicate that AβP1-40
conformation in an aqueous environment is predominantly
β-sheet and random coil, while the α-helical content is very
small. Our results are in line with other authors’ ﬁndings
[11]. The features of the spectra show that choline at the two
concentrationsuseddoesnotmodifythesecondarystructure
of the peptide. Moreover, it increases the signal intensity
after 24 and 48 hours of incubation. This could mean8 International Journal of Alzheimer’s Disease
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Figure 5: AβP1-40 channel activity in POPC:Ch PLM. Representative AβP1-40 channel in the absence (a) or in the presence of choline
(5 ×10−11M) on the cis ( b )o ro nt h etrans (c) side of the medium facing a POPC:Ch (65:35, w/w) PLM at an applied voltage of 60mV.
Amplitude histograms of channel conductance for each trace are shown next to their respective traces.
Table 2:ThechannellifetimeofAβP1-40inPOPC:ChPLM.Theﬁttedlifetime(seetext)ofAβP1-40(a),AβP1-40andcholine(5 ×10−11 M)
added to the cis/trans side of the chamber (b/c, resp.) channels in the POPC:Ch membrane. The minimum and maximum number of
channels considered (N) out of a total number of channels considered (Nt) was: (a) 94 <N < 240, Nt = 448; (b) 120 <N<196,
Nt = 435; (c) 19 <N<111, Nt = 205. F-test, ∗P ≥ .078; ∗∗P = .39;
∗∗∗P = 0.37.
Vs (mV) ab c
τ1
∗ (s) τ1 (s) τ1 (s)
100 2.50 1.72
∗∗ —
80 3.13 3.03 2.99
∗∗∗
60 3.25 2.32 3.11
that choline stabilizes the AβP1-40 structure, counteracting
peptide aggregation.
3.5. Choline Permeability across Undoped and Doped OxCh
Membranes. Control experiments were designed to test the
eﬀect of ethanol on membrane integrity. The addition of
4μl of ethanol to both sides of the OxCh membrane, under
stirring, does not inﬂuence the capacitance (0.32μF/cm2)
and the conductance (25pS) of the membrane over a long
period of time (about 6 hours).International Journal of Alzheimer’s Disease 9
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Figure 6: AβP1-40 channel mean conductance and frequency in
POPC:Ch PLM. (a) Λc ± SE and (b) frequency ± SD of AβP1-40
channel without and with choline (5 ×10−11 M) (added to the cis
or trans side of the chamber) in POPC:Ch (65:35, w/w) PLM. The
minimum and maximum number of channels considered (N)o u t
of a total number of channels considered (Nt)w a s :A βP1-40, 761 <
N<1283, Nt = 2928; AβP1-40 + choline cis, 449 <N<1320,
Nt = 2305; AβP1-40 + choline trans, 170 <N<624, Nt =
1269.
The permeability coeﬃcients of [3H]choline across the
OxCh membrane, undoped and doped with AβP1-40, were:
47.1 ± 2.14 and 43.8 ± 7.9 (cm × sec−1×10−6), respectively.
This data indicates that choline, despite showing a high
permeability coeﬃcient across OxCh membranes, is unable
to cross the AβP1-40 channel.
4. Discussion
Early evidence showed that AβP1-40 is initially deposited on
the membranes and acts as a “seed” for the formation of ﬁb-
rils [19], although the involvement of AβPﬁ b r i l l a t i o nin vivo
in the process of neurodegeneration and the development of
AD is not an irrefutable criterion for deﬁning the pathology.
Recent studies have shown that AβP induces toxicity on
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Figure 7: AβP1-40 channel ion selectivity in OxCh PLM. AβP1-40
channel selectivity in the presence of choline (5 × 10−11 M) cis (a)
or trans (b) in OxCh PLM. The amplitude of the channel current
(pA) is plotted as a function of the transmembrane potential
(V). Conductance was determined by linear regression of the
current values from −30/−20mV to 40/20mV (choline cis/trans)
in asymmetrical solutions 100mM/50 mM KCl cis/trans.I n t e r c e p t
(5.76/7.76mV, choline cis/trans) was used to calculate PK
+/PCl
−.
cholinergic neurons in vitro and in vivo by increasing,
via distinct mechanisms, Ach turnover. In neuronal cells,
choline is a precursor of ACh, but also a product of
ACh hydrolysis after the neurotransmission process. The
mechanisms involved in cholinergic dysfunction are under
intense investigation because of their potential therapeutical
implications [20]. Although the basal extracellular choline
concentration is higher (about 5μM) [21]a sc o m p a r e dt o
the concentration used in the present study, the sensitivity
of our experimental system, suitable for high-resolution ion
current recordings, does not allow us to use choline concen-
tration higher than 1.5 ×10−8 M. In fact, the activation of
AβP channels by choline at concentration higher than 1.5
×10−8 M generates an electrical signal that is so large that
it exceeds the maximum level of detection by the recording
system furthermore, these conditions will lead to membrane
instability eventually resulting in membrane breakage.
The human brain contains as much as 25% of the total
pool of Ch, mainly concentrated in the myelin sheath. How-
ever, there are also considerable amounts of Ch in neuronal
plasmalemma and in lipid rafts. One interesting aspect of
the Ch molecule seems to be its aﬃnity for many proteins
such as porins [22, 23], for peptides such as magainin-
2[ 24], AβP1-40 and AβP1-42 [14], and for peptides
associated with myelin; examples of Ch-dependent proteins10 International Journal of Alzheimer’s Disease
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Figure 8: AβP1-40 channel ion selectivity in POPC:Ch PLM.
AβP1-40 channel selectivity (a), in the presence of choline (5
×10−11 M) cis (b) or trans (c) side in POPC:Ch (65:35, w/w)
PLM. The amplitude of the channel current (pA) is plotted as
a function of the transmembrane potential (V). Conductance
was determined by linear regression of the current values from
−150 to 100mV (a) and from −40/−80mV to 40/40mV (choline
cis/trans) in asymmetrical 100mM/50mM KCl cis/trans solutions.
Intercept(9.76/5.76/7.76mV,(a)/(b)/(c)resp.)wasusedtocalculate
PK
+/PCl
−.
are prominin, synaptophysin, platelet-derived growth fac-
tor receptor, hemolysin, acetylcholine-receptor, peripheral
myelin protein 22, and prions [25–31]. In particular, it has
been demonstrated that Ch at a concentration of 33% in
modelmembranesandinvesiclescanfavourthetransitionof
AβP1-40 and human cytoplasmic domain of myelin protein
zero into alpha helix [32]. On the other hand, membrane
Chinducesthestructuralconformationofmanypeptidesfor
incorporation.
Results in OxCh and POPC:Ch planar lipid membranes
(PLMs) conﬁrm our previous ﬁndings [14] and further
indicate the role played by membrane composition in the
alpha-helix structure induction mechanism needed for AβP
incorporation into membranes. Furthermore, we found
220 240 260
C
D
(
m
d
e
g
)
Wavelength (nm)
−8
−4
0
4
8
(a)
220 240 260
C
D
(
m
d
e
g
)
Wavelength (nm)
−8
−6
−4
−2
0
2
(b)
220 240 260
C
D
(
m
d
e
g
)
Wavelength (nm)
−10
−8
−6
−4
−2
0
2
AβP1-40
AβP1-40 + choline 5 ×10−9 M
AβP1-40 + choline 5 ×10−8 M
(c)
Figure 9: AβP1-40 secondary structure. Far-UV CD spectroscopy
of AβP1-40 (5 ×10−6 M) in the absence and in the presence of
choline (5.77 × 10−8M; 5.77 × 10−9M) after 5 minutes (a), 24
hours (b) and 48 hours (c) of incubation. See text for experimental
conditions.
sensitivity to choline addition of AβP channels incorporated
into OxCh PLMs; indeed, choline does not modify some
channel characteristics, such as voltage sensitivity, voltage-
dependence, and selectivity, but increases channel conduc-
tance, frequency, and stability, as indicated by the presence
of two channel life-time components.International Journal of Alzheimer’s Disease 11
In the Type I AβP1-40 channel model proposed by
Durell et al. [33], the amino acids able to form hydrogen
bonds could be R5, D7, E11, K16, and D23. This has
been invoked to explain the cation selectivity of the AβP1-
40 channel. The AβP1-40 channel incorporated in our
membranes is anion selective. Choline does not modify
the anion selectivity of AβP channel incorporated in OxCh
membrane, the aggregated conﬁguration of AβPp e p t i d e
could be diﬀerent, although this channel shows the same
diameter, as reported in our previous paper [14], found in
the theoretical calculation of the model proposed by Durell
et al. [33].
Incorporation in POPC PLMs containing 33% Ch seems
to be driven by hydrophobic interaction, as the high
hydrophobic amino acid content in the C-terminus of AβP1-
40 would suggest. Furthermore, our results seem to indicate
that the AβP1-40 channel is smaller than that formed in
OxCh membranes, which could reﬂect a lower number
of AβP1-40 molecules assembled to form ion channels.
However, it is worth noting that in POPC:Ch PLMs, the
channel maintains its anionic selectivity, thus pushing the
membrane into a hyperpolarized state.
Our CD results, obtained in an aqueous environment,
indicate that choline does not modify AβP1-40 peptide
conformation but rather stabilizes it in a random coil
conformation that is less prone to ﬁbrillate. This result is
consistent with the notion that the role played by choline
is to counteract peptide aggregation, by maintaining it in
the stabilized random coil form, so that in the membrane
alpha-helices will arise in the peptide that tend to pack
together to form ion channel rather than remain dispersed.
Hydrogen bonds and ion pairs can be used to drive the
associationoflocalregionsinthehelices[34].Itisinteresting
to note that Kar et al. [9] found a concentration-dependent
inhibition of high-aﬃnity choline uptake by AβPi nr a t
hippocampal slides, indicating a direct interaction between
AβP and choline. AβP1-40 present on the extracellular side
of PC12 cells as a monomer has been found to increase the
conductanceofcholinetrappedinsidecells.Theauthors[35]
suggest that AβP1-40 peptide acts as a choline carrier or
that it modiﬁes an endogenous ion channel or transporter.
However, a suggestive possibility could be that choline
crosses the AβP1-40 channel. To verify this possibility,
permeability experiments on OxCh PLMs have been carried
out.Inourexperimentalconditions,wheretherearenoother
cellularcomponents exceptforthe AβP1-40 channel, choline
does not cross the AβP1-40 channel.
Study of the eﬀects of ACh on AβP1-40 by means of
CD indicates that ACh has no eﬀect on peptides in solution;
moreover,singlechannelconductancedecreaseswhenAChis
a d d e do nt h ecis side when the channel is open; on the other
hand, in the same experimental conditions, ACh addition on
the transside did not modify channel conductance [36]. This
indicates a speciﬁc eﬀect of choline on AβP1-40.
5. Conclusions
Our present ﬁndings support and extend the emerging
concept that cholesterol can easily incorporate AβP1-40,
thus favouring its clearance; therefore, by removing the
peptide from the environment, ﬁbrillation will be avoided.
Furthermore, the anionic nature of the AβP1-40 channel
formed in cholesterol-containing PLMs could be protective
for the cells. Choline speciﬁcally accelerates this process. The
greater eﬀect of choline on depolarized membrane states
found in this work could be of relevance for synaptic activity
in that the higher ionic conductance, frequency and lifetime,
as well as the anionic selectivity, all contribute to returning
the membrane potential to basal condition. This could exert
a kind of modulation on the synapses.
It may be speculated that owing to the high choline
permeability found across the OxCh membrane, and the in
vivo facilitated/active choline transport, ACh synthesis takes
place quickly. The increase in ACh delivery and/or ACh
esterase modulation may be beneﬁcial to synaptic activity.
Obviously, these aspects are merely speculative because we
do not have any evidence that this occurs in vivo.
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